A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
about
Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumoursA phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumorsTargeting protein prenylation for cancer therapyA phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.Mechanisms of Chromosome Congression during Mitosis.
P2860
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A Phase I trial of the farnesy ...... patients with advanced cancer.
@ast
A Phase I trial of the farnesy ...... patients with advanced cancer.
@en
type
label
A Phase I trial of the farnesy ...... patients with advanced cancer.
@ast
A Phase I trial of the farnesy ...... patients with advanced cancer.
@en
prefLabel
A Phase I trial of the farnesy ...... patients with advanced cancer.
@ast
A Phase I trial of the farnesy ...... patients with advanced cancer.
@en
P2093
P1476
A Phase I trial of the farnesy ...... patients with advanced cancer.
@en
P2093
Alain Thibault
Alex A Adjei
Charles Erlichman
Gary A Croghan
Henry C Pitot
Jeff A Sloan
Joel M Reid
Laura M Bruzek
Lorelei J Hanson
Pamela Atherton
P304
P407
P577
2003-07-01T00:00:00Z